Related Experiment Video
Updated: Jun 17, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Bone and joint involvement in Fabry disease
K Sacre1, Olivier Lidove, B Giroux Leprieur
1Department of Internal Medicine, Bichat-Claude Bernard Hospital, APHP, University Paris-7, Paris Cedex 18, France.
Insights
Fabry disease (FD), a genetic disorder, often leads to bone density loss (osteoporosis) and joint issues in affected individuals. This study highlights skeletal complications in four family members with classic FD, emphasizing the need for further research.
Area of Science:
- Genetics
- Metabolic Disorders
- Skeletal Biology
Background:
- Fabry disease (FD) is an X-linked lysosomal storage disorder resulting from deficient alpha-galactosidase A activity.
- While FD affects multiple organ systems, its impact on skeletal health remains under-documented.
- Understanding the full spectrum of FD manifestations is crucial for comprehensive patient care.
Observation:
- Four related patients (3 males, 1 premenopausal female) with classic FD phenotype were studied.
- All patients exhibited osteoporosis or osteopenia via dual-energy X-ray absorptiometry.
- One patient presented with neuropathic joint disease and osteonecrosis.
Findings:
- Skeletal involvement, including osteoporosis and osteopenia, is prevalent in individuals with Fabry disease.
- The study identified osteoporotic fractures and advanced joint complications in FD patients.
- Specific mechanisms contributing to bone and joint pathology in FD were explored.
Implications:
- These findings underscore the significance of skeletal health monitoring in Fabry disease management.
- Further research into the pathogenesis of skeletal complications in FD is warranted.
- Integrating skeletal assessments may improve the holistic care of patients with Fabry disease.
Abstract:
Fabry disease (FD) is an X-linked lysosomal storage disease caused by deficient activity of the enzyme alpha-galactosidase A. Although the disease has progressive effects on most organ systems in the body, data is limited regarding skeletal involvement in this rare disorder. We describe four family-related patients, three men and one premenopausal female, sharing a classic phenotype of FD. Dual-energy X-ray was performed in all cases and osteoporosis or osteopenia were found in all patients and osteoporotic fractures in one. One patient also showed both neuropathic joint disease and osteonecrosis. Several mechanisms that may explain osteoporosis and osteoarthropathy in the setting of FD are emphasized.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Bone as Supporting Connective Tissue
Bone Matrix
Bone, or osseous tissue, is a connective tissue that has a large amount of two different types of matrix material. The organic matrix is similar to the matrix material found in other connective tissues, including some amount of collagen and elastic fibers. This gives strength and flexibility to the tissue. The inorganic matrix consists of mineral salts— mostly calcium salts— that give the...
Bone Remodeling and Repair
Fractures: Bone Repair
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Rheumatic Heart Disease I: Introduction

